Industry: Pharma & Healthcare
Published Date: 2024-04-16
Pages: 121 Pages
Report ld: 2687342
Request Sample
Customized Report
Mildronate is a registered trademark of the Grindex. Its active substance is meldonium. Meldonium is a limited-market pharmaceutical, and is an ‘anti-ischemic’ drug, which means it is used to treat inadequate blood-flow to the organs, especially the heart. It is primarily used to treat patients with heart conditions that affect the body’s ability to deliver oxygen to the body. It helps to protect against tissue damage from angina attacks, chronic heart failure and disorders of brain circulation.
The global Mildronate Dihydrate market is projected to reach US$ million by 2030 from an estimated US$ million in 2024, at a CAGR of % during 2024 and 2030.
In Europe, Mildronate Dihydrate key players include Grindeks, etc. Global top one manufacturers hold a share over 99%.
Russia is the largest market, with a share about 40%, followed by Latvia, and Lithuania, both have a share over 5 percent.
In terms of product, Capsule is the largest segment, with a share over 55%. And in terms of application, the largest application is Cardiovascular Disease, etc.
MARKET SEGMENTATION
REPORT SCOPE
This report aims to provide a comprehensive presentation of the global market for Mildronate Dihydrate, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Mildronate Dihydrate.
The Mildronate Dihydrate market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Mildronate Dihydrate market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Mildronate Dihydrate manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application, and regions.
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Mildronate Dihydrate in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Mildronate Dihydrate manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Mildronate Dihydrate sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Mildronate Dihydrate Product Introduction
1.2 Market by Type
1.2.1 Global Mildronate Dihydrate Market Size Growth Rate by Type (2019 VS 2023 VS 2030)
1.2.2 Capsule
1.2.3 Injection
1.2.4 Tablet
1.3 Market by Application
1.3.1 Global Mildronate Dihydrate Market Size Growth Rate by Application (2019 VS 2023 VS 2030)
1.3.2 Cardiovascular Disease
1.3.3 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Mildronate Dihydrate Market Size Estimates and Forecasts
2.1.1 Global Mildronate Dihydrate Revenue 2019-2030
2.1.2 Global Mildronate Dihydrate Sales 2019-2030
2.2 Mildronate Dihydrate Market Size by Region: 2023 Versus 2030
2.3 Mildronate Dihydrate Sales by Region (2019-2030)
2.3.1 Global Mildronate Dihydrate Sales by Region: 2019-2024
2.3.2 Global Mildronate Dihydrate Sales Forecast by Region (2025-2030)
2.3.3 Global Mildronate Dihydrate Sales Market Share by Region (2019-2030)
2.4 Mildronate Dihydrate Market Estimates and Projections by Region (2025-2030)
2.4.1 Global Mildronate Dihydrate Revenue by Region: 2019-2024
2.4.2 Global Mildronate Dihydrate Revenue Forecast by Region (2025-2030)
2.4.3 Global Mildronate Dihydrate Revenue Market Share by Region (2019-2030)
3 Global Mildronate Dihydrate by Manufacturers
3.1 Global Top Mildronate Dihydrate Manufacturers by Sales
3.1.1 Global Mildronate Dihydrate Sales by Manufacturer (2019-2024)
3.1.2 Global Mildronate Dihydrate Sales Market Share by Manufacturer (2019-2024)
3.2 Global Top Mildronate Dihydrate Manufacturers by Revenue
3.2.1 Global Mildronate Dihydrate Revenue by Manufacturer (2019-2024)
3.2.2 Global Mildronate Dihydrate Revenue Share by Manufacturer (2019-2024)
3.3 Global Mildronate Dihydrate Price by Manufacturer (2019-2024)
3.4 Competitive Landscape
3.4.1 Key Mildronate Dihydrate Manufacturers Covered: Ranking by Revenue
3.4.2 Global Mildronate Dihydrate Market Concentration Ratio (CR5 and HHI) & (2019-2024)
3.4.3 Global Mildronate Dihydrate Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global Mildronate Dihydrate Manufacturing Base Distribution, Product Type
3.5.1 Mildronate Dihydrate Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers Mildronate Dihydrate Product Type
3.5.3 Date of International Manufacturers Enter into Mildronate Dihydrate Market
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 Grindeks
4.1.1 Grindeks Company Information
4.1.2 Grindeks Description, Business Overview
4.1.3 Grindeks Mildronate Dihydrate Products Offered
4.1.4 Grindeks Mildronate Dihydrate Sales, Revenue and Gross Margin (2019-2024)
4.1.5 Grindeks Mildronate Dihydrate Sales by Product in 2023
4.1.6 Grindeks Mildronate Dihydrate Sales by Application in 2023
4.1.7 Grindeks Mildronate Dihydrate Sales by Geographic Area in 2023
4.1.8 Grindeks Recent Developments
5 Breakdown Data by Type
5.1 Global Mildronate Dihydrate Sales by Type (2019-2030)
5.1.1 Global Mildronate Dihydrate Sales by Type (2019-2024)
5.1.2 Global Mildronate Dihydrate Sales Forecast by Type (2025-2030)
5.1.3 Global Mildronate Dihydrate Sales Market Share by Type (2019-2030)
5.2 Global Mildronate Dihydrate Revenue Forecast by Type (2019-2030)
5.2.1 Global Mildronate Dihydrate Revenue by Type (2019-2024)
5.2.2 Global Mildronate Dihydrate Revenue Forecast by Type (2025-2030)
5.2.3 Global Mildronate Dihydrate Revenue Market Share by Type (2019-2030)
5.3 Mildronate Dihydrate Average Selling Price (ASP) by Type (2019-2030)
6 Breakdown Data by Application
6.1 Global Mildronate Dihydrate Sales by Application (2019-2030)
6.1.1 Global Mildronate Dihydrate Sales by Application (2019-2024)
6.1.2 Global Mildronate Dihydrate Sales Forecast by Application (2025-2030)
6.1.3 Global Mildronate Dihydrate Sales Market Share by Application (2019-2030)
6.2 Global Mildronate Dihydrate Revenue Forecast by Application (2019-2030)
6.2.1 Global Mildronate Dihydrate Revenue by Application (2019-2024)
6.2.2 Global Mildronate Dihydrate Revenue Forecast by Application (2025-2030)
6.2.3 Global Mildronate Dihydrate Revenue Market Share by Application (2019-2030)
6.3 Mildronate Dihydrate Average Selling Price (ASP) by Application (2019-2030)
7 North America
7.1 North America Mildronate Dihydrate Market Size YoY Growth 2019-2030
7.2 North America Mildronate Dihydrate Market Facts & Figures by Country
7.2.1 North America Mildronate Dihydrate Sales by Country (2019-2030)
7.2.2 North America Mildronate Dihydrate Revenue by Country (2019-2030)
7.3 North America Mildronate Dihydrate Sales by Type (2019-2024)
7.4 North America Mildronate Dihydrate Sales by Application (2019-2024)
8 Asia-Pacific
8.1 Asia-Pacific Mildronate Dihydrate Market Size YoY Growth 2019-2030
8.2 Asia-Pacific Mildronate Dihydrate Market Facts & Figures by Region
8.2.1 Asia-Pacific Mildronate Dihydrate Sales by Region (2019-2030)
8.2.2 Asia-Pacific Mildronate Dihydrate Revenue by Region (2019-2030)
8.3 Asia-Pacific Mildronate Dihydrate Sales by Type (2019-2024)
8.4 Asia-Pacific Mildronate Dihydrate Sales by Application (2019-2024)
9 Europe
9.1 Europe Mildronate Dihydrate Market Size YoY Growth 2019-2030
9.2 Europe Mildronate Dihydrate Market Facts & Figures by Country
9.2.1 Europe Mildronate Dihydrate Sales by Country (2019-2030)
9.2.2 Europe Mildronate Dihydrate Revenue by Country (2019-2030)
9.3 Europe Mildronate Dihydrate Sales by Type (2019-2024)
9.4 Europe Mildronate Dihydrate Sales by Application (2019-2024)
10 Latin America
10.1 Latin America Mildronate Dihydrate Market Size YoY Growth 2019-2030
10.2 Latin America Mildronate Dihydrate Market Facts & Figures by Country
10.2.1 Latin America Mildronate Dihydrate Sales by Country (2019-2030)
10.2.2 Latin America Mildronate Dihydrate Revenue by Country (2019-2030)
10.3 Latin America Mildronate Dihydrate Sales by Type (2019-2024)
10.4 Latin America Mildronate Dihydrate Sales by Application (2019-2024)
11 Middle East and Africa
11.1 Middle East and Africa Mildronate Dihydrate Market Size YoY Growth 2019-2030
11.2 Middle East and Africa Mildronate Dihydrate Market Facts & Figures by Country
11.2.1 Middle East and Africa Mildronate Dihydrate Sales by Country (2019-2030)
11.2.2 Middle East and Africa Mildronate Dihydrate Revenue by Country (2019-2030)
11.3 Middle East and Africa Mildronate Dihydrate Sales by Type (2019-2024)
11.4 Middle East and Africa Mildronate Dihydrate Sales by Application (2019-2024)
12 Supply Chain and Sales Channel Analysis
12.1 Mildronate Dihydrate Supply Chain Analysis
12.2 Mildronate Dihydrate Key Raw Materials and Upstream Suppliers
12.3 Mildronate Dihydrate Clients Analysis
12.4 Mildronate Dihydrate Sales Channel and Sales Model Analysis
12.4.1 Mildronate Dihydrate Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Mildronate Dihydrate Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Mildronate Dihydrate Distributors
13 Market Dynamics
13.1 Mildronate Dihydrate Industry Trends
13.2 Mildronate Dihydrate Market Drivers
13.3 Mildronate Dihydrate Market Challenges
13.4 Mildronate Dihydrate Market Restraints
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Mildronate Dihydrate market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 71
USD 4250.00
(Single User License)
The global Mildronate Dihydrate market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-04
Pages: 95
USD 2900.00
(Single User License)
The global market for Mildronate Dihydrate was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-04
Pages: 85
USD 3950.00
(Single User License)
The global Mildronate Dihydrate market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-11
Pages: 122
USD 4900.00
(Single User License)
In 2024, the global market size of Mildronate Dihydrate was estimated to be worth US$ million and is forecast to reach approximately US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 116
USD 5900.00
(Single User License)
The global Mildronate Dihydrate market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-19
Pages: 67
USD 4250.00
(Single User License)
The global market for Mildronate Dihydrate was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 90
USD 3950.00
(Single User License)
The global market for Mildronate Dihydrate was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-01-16
Pages: 68
USD 2900.00
(Single User License)
Mildronate is a registered trademark of the Grindex. Its active substance is meldonium. Meldonium is a limited-market pharmaceutical, and is an ‘anti-ischemic’ drug, which means it is used to treat inadequate blood-flow to the organs, especially the heart. It is primarily used to treat patients with heart conditions that affect the body’s ability to deliver oxygen to the body. It helps to protect against tissue damage from angina attacks, chronic heart failure and disorders of brain circulation.
Published Date: 2024-04-17
Pages: 122
USD 5600.00
(Single User License)
Mildronate is a registered trademark of the Grindex. Its active substance is meldonium. Meldonium is a limited-market pharmaceutical, and is an ‘anti-ischemic’ drug, which means it is used to treat inadequate blood-flow to the organs, especially the heart. It is primarily used to treat patients with heart conditions that affect the body’s ability to deliver oxygen to the body. It helps to protect against tissue damage from angina attacks, chronic heart failure and disorders of brain circulation.
Published Date: 2024-04-07
Pages: 71
USD 4900.00
(Single User License)
The global Mildronate Dihydrate market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 71
The global Mildronate Dihydrate market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-04
Pages: 95
The global market for Mildronate Dihydrate was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-01-04
Pages: 85
The global Mildronate Dihydrate market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-11
Pages: 122
In 2024, the global market size of Mildronate Dihydrate was estimated to be worth US$ million and is forecast to reach approximately US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 116
The global Mildronate Dihydrate market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-19
Pages: 67
The global market for Mildronate Dihydrate was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 90
The global market for Mildronate Dihydrate was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-01-16
Pages: 68
Mildronate is a registered trademark of the Grindex. Its active substance is meldonium. Meldonium is a limited-market pharmaceutical, and is an ‘anti-ischemic’ drug, which means it is used to treat inadequate blood-flow to the organs, especially the heart. It is primarily used to treat patients with heart conditions that affect the body’s ability to deliver oxygen to the body. It helps to protect against tissue damage from angina attacks, chronic heart failure and disorders of brain circulation.
Published: 2024-04-17
Pages: 122
Mildronate is a registered trademark of the Grindex. Its active substance is meldonium. Meldonium is a limited-market pharmaceutical, and is an ‘anti-ischemic’ drug, which means it is used to treat inadequate blood-flow to the organs, especially the heart. It is primarily used to treat patients with heart conditions that affect the body’s ability to deliver oxygen to the body. It helps to protect against tissue damage from angina attacks, chronic heart failure and disorders of brain circulation.
Published: 2024-04-07
Pages: 71
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
REPORT SCOPE
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now